Ref: IMD-3-2171

Case study

Reference: IMD-3-2171

Order this case study

SMS for life (C): Sustaining the initiative and leveraging its social and business value for Novartis

By Emeritus Professor Donald A. Marchand Donald A. Marchand

This third and final part of the "SMS for Life" case series concentrates on the institutional response to the question of how Novartis could sustain and leverage the capabilities of SMS for Life project to improve the demand/supply of other medicines in addition to malaria prescriptives in the private distribution of drugs in emerging markets globally with new partnerships and ventures. Jim Barrington had come a long way since his meeting with his boss, Raymond Breu, Novartis’s CFO in December 2008. Breu had agreed to fund Jim for a 12-month period to launch what became the SMS for Life project. Jim had clearly overcome Breu’s concerns that the project would be too complex, hard to fund and very political with the involvement of national governments, NGOs, private companies and the WHO. As Jim completed the successful pilot in Tanzania in February 2010 and delivered the final project report to Roll Back Malaria in April 2010, the institutional response to the question of how Novartis as a company would sustain and leverage the SMS for Life project would also evolve. Learning objectives: The learning objectives are twofold: 1) to debate Novartis’s institutionalization of the SMS for Life initiative and 2) to discuss Barrington’s succession. The participants are required to construe the role of the Novartis business and the IT organization in sustaining and developing the SMS initiative but also to develop their own understanding of how this effort is moving forward.

Learning Objective

The learning objectives are twofold:

  1. to debate Novartis’s institutionalization of the SMS for Life initiative and
  2. to discuss Barrington’s succession. The participants are required to construe the role of the Novartis business and the IT organization in sustaining and developing the SMS initiative but also to develop their own understanding of how this effort is moving forward.
KeywordsBusiness Innovation, Collaboration, General Management, Information Management, Malaria, Public-Private Partnership, Supply Chain, Value Constellation
SettingsAfrica, Tanzania
Novartis, Pharmaceuticals
2011-2012
TypeField Research
Copyright©2012
Order this case study

Reference: IMD-3-2171

IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Fax +44 (0)1234 751125
Email info@thecasecentre.org

The Case Centre Babson College

Babson Park Wellesley MA 02457, USA
Tel +1 781 239 5884
Fax +1 781 239 5885
Email info.usa@thecasecentre.org

Harvard Business School Publishing

60 Harvard Way Boston, MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email custserv@hbsp.harvard.edu

Case Center Japan

2nd Floor, Toranomon Jitsugyokaikan,
1-1-20 Toranomon, Minato-ku,
Tokyo 105-0001 Japan
Tel +81 3 3503 6621
Fax +81 3 3501 0550
Email info@casecenter.jp

Copyright information

IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information, please contact our Information Center.

Do you need more information?
Contact us for additional information or republishing

Case study

Reference: IMD-3-2171

Order this case study

Looking for something specific?

Keep reading

Back to top